S. Korea Doctors Cleared To Bypass H1N1 Tests Before Giving Tamiflu
This article was originally published in PharmAsia News
South Korea's CDC has cleared the nation's physicians to provide Roche's Tamiflu (oseltamivir) without having to conduct infection tests for the H1N1 flu virus. The KCDC also said that despite concerns about the antiviral's side effects, it would provide a list of hospitals and pharmacies where the public can obtain the drug. The KCDC's director said it was aware of the risk and that there is some resistance to Tamiflu, but the agency decided the need to slow the spread of the virus was more important. (Click here for more
You may also be interested in...
Mylan and Pfizer’s Upjohn, already facing a delay to their proposed merger, may have to overcome regulatory barriers to get the deal over the line.
National export restrictions on medicines have been slammed by the international off-patent pharmaceutical industry as being “counter-productive” during the coronavirus crisis. The IGBA is instead urging international co-operation and transparency, pointing to a positive example of supply-chain connectivity in the Asia-Pacific region.
Claims circulated on social media that its Cebion supplement could prevent coronavirus has led Italy's Dompé to take legal action.